In Vitro-Transcribed mRNAs as a New Generation of Therapeutics in the Dawn of Twenty-First Century: Exploitation of Peptides as Carriers for Their Intracellular Delivery-Reference-Cited by-同舟云学术

In Vitro-Transcribed mRNAs as a New Generation of Therapeutics in the Dawn of Twenty-First Century: Exploitation of Peptides as Carriers for Their Intracellular Delivery

Published:2022 Issue: Volume: Page:209-235
ISSN:2197-9731
Container-title:RNA Technologies
language:
Short-container-title:

Author:

Miliotou A. N.,Pappas I. S.,Vizirianakis I. S.,Papadopoulou L. C.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-08415-7_10

Reference138 articles.

1. Ahlemeyer B, Vogt JF, Michel V et al (2014) Microporation is an efficient method for siRNA-induced knockdown of PEX5 in HepG2 cells: evaluation of the transfection efficiency, the PEX5 mRNA and protein levels and induction of peroxisomal deficiency. Histochem Cell Biol 142:577–591

2. Alberer M, Gnad-Vogt U, Hong HS et al (2017) Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet 390:1511–1520

3. Aldrian-Herrada G, Desarmenien MG, Orcel H et al (1998) A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Acids Res 26:4910–4916

4. Andaloussi SE, Lehto T, Mager I et al (2011) Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo. Nucleic Acids Res 39:3972–3987

5. Andries O, Mc Cafferty S, De Smedt SC et al (2015) N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J Control Release 217:337–344

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Technologien und Lösungsansätze für die effiziente Herstellung von Zelltherapeutika für die CAR-Immuntherapie;Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft;2023-12-30

2. mRNA‐based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directions;Interdisciplinary Medicine;2023-12-29